Emmaus Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

INCOME TAX (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
INCOME TAX (Details Narrative) - USD ($)	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Income tax provision (benefit)	$ (499,000)	$ 51,000	$ (213,000)	$ 103,000
Provision for federal income tax			0
Unrecognized tax benefit	$ 0		$ 0		$ 0

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.